Research output per year
Research output per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Doctor of Philosophy, Observations on the immunological anti-tumour effects of Swainsonine, a glycosylation inhibitor, Imperial College London
Award Date: 1 Jan 1996
Bachelor of Science, King's College London
Award Date: 1 Jan 1990
Fingerprint
Dive into the research topics where Christine Galustian is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Editorial: Immunotherapy for Prostate Cancer – turning the immunological desert into an oasis of hope
Galustian, C., Dalgleish, A., Bodman-Smith, M., Kusmartsev, S. & Dasgupta, P., 8 Sept 2022, In: Frontiers in oncology. 12, 1021870.Research output: Contribution to journal › Editorial › peer-review
Open Access2 Citations (Scopus) -
Editorial: Immunotherapy for Prostate Cancer - turning the immunological desert into an oasis of hope
Galustian, C., Dalgleish, A., Bodman-Smith, M., Kusmartsev, S. & Dasgupta, P., 8 Sept 2022, (E-pub ahead of print) In: Frontiers in oncology. 12, p. 1021870Research output: Contribution to journal › Editorial › peer-review
Open Access -
Combination of Interleukin-15 with a STING agonist, ADU-S100 analog: a potential immunotherapy for prostate cancer
Da Silva Esteves, A. M., Papaevangelou, E., Dasgupta, P. & Galustian, C., 12 Jan 2021, (Accepted/In press) In: Frontiers in oncology.Research output: Contribution to journal › Article › peer-review
Open AccessFile80 Downloads (Pure) -
Cytotopic (Cyto-) IL-15 as a New Immunotherapy for Prostate Cancer: Recombinant Production in Escherichia coli and Purification
Esteves, A. M., Papaevangelou, E., Smolarek, D., Dasgupta, P. & Galustian, C., 27 Oct 2021, In: Frontiers in Molecular Biosciences. 8, 755764.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus) -
IL-15 upregulates telomerase expression and potently increases proliferative capacity of NK, NKT-like, and CD8 T cells
Watkinson, F., Nayar, S., Rani, A., Sakellariou, C., Elhage, O., Papaevangelou, E., Dasgupta, P. & Galustian, C., 18 Jan 2021, In: Frontiers in Immunology. 11, p. 594620 1 p., 594620.Research output: Contribution to journal › Article › peer-review
Open AccessFile20 Citations (Scopus)128 Downloads (Pure)
-
Novel Immunotherapies for Prostate Cancer –from bench to bedside
Galustian, C., Dasgupta, P. & Papaevangelou, E.
1/03/2020 → 31/07/2022
Project: Research
-
Development of cytotopically modified IL-15 for treatment of prostate cancer
Galustian, C., Blower, P., Dasgupta, P., Eykyn, T., Papaevangelou, E., Smith, R. & academic, A.
1/07/2017 → 30/06/2019
Project: Research
-
Development of cytotopically modified IL-15 for treatment of prostate cancer
Galustian, C., Dasgupta, P., Smith, R. & academic, A.
1/10/2016 → 30/09/2018
Project: Research
Activities
- 1 Types of External academic engagement - Contribution to the work of national or international committees and working groups
-
Afro-Caribbean Research action group member - Prostate Cancer UK
Christine Galustian (Member)
1 Mar 2014Activity: Other › Types of External academic engagement - Contribution to the work of national or international committees and working groups